Fulgent Genetics unveils FulGenome upgrade with higher repeat expansion detection

Fulgent Genetics unveils FulGenome upgrade with higher repeat expansion detection
Fulgent updates FulGenome WGS tool

Fulgent Genetics has announced a major update to its FulGenome whole genome sequencing (WGS) solution. The latest version now detects 64 repeat expansions, a significant increase from the previous capability of 20, all consolidated into one streamlined report.

This enhancement is aimed at improving the clinical utility of WGS by providing broader coverage of repeat expansion disorders in a single test. The update positions Fulgent Genetics as a leader in advanced genomic diagnostics as demand grows for comprehensive genetic testing solutions.

Fulgent Genetics recently shared updated Phase 2 data for its FID-007 candidate in combination with cetuximab and announced upcoming plans for a Phase 3 trial at ASCO26, according to a prior disclosure. The company also outlined efforts to increase industry engagement at the APG2026 Exhibit Fair and Strolling Dinner in San Diego, as detailed in a separate event summary. These initiatives reflect a continued expansion of Fulgent's clinical and industry presence.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.